Activation of oxidative stress response by hydroxyl substituted chalcones and cyclic chalcone analogues in mitochondria

FEBS Letters

Volumn 584, Issue 3, 2010, Pages 567-570

  Guzy, J ^a   Vaskova Kubalkova J ^a   Rozmer, Z ^b   Fodor, K ^b   Marekova M ^a   Poskrobova M ^a   Perjesi P ^b  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cyclic chalcone analogue; Glutathione; Hydroxyl radical; Mitochondria; Oxidative stress; Respiration

Indexed keywords

4 HYDROXYCHALCONE; CHALCONE DERIVATIVE; GLUTATHIONE; QUERCETIN; REACTIVE OXYGEN METABOLITE; THIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ELECTRON TRANSPORT; LIVER MITOCHONDRION; MALE; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT;

ANIMALS; CHALCONES; ELECTRON TRANSPORT; ENERGY METABOLISM; GLUTATHIONE; MALE; MITOCHONDRIA; MOLECULAR STRUCTURE; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; RATS, WISTAR;

RATTUS;

EID: 74349103322     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.11.098     Document Type: Article

References (35)

1. Harborne J.B. Nature, distribution, and function of plant flavonoids. In: Cody V., Middleton Jr. E., and Harborne J.B. (Eds). Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships (1986), Alan R. Liss. Inc., New York 15-24
2. Nakamura Y., Watanabe S., Miyake N., Kohno H., and Osawa T. Dihydrochalcones: evaluation as novel radical scavenging antioxidants. J. Agric. Food Chem. 51 (2003) 3309-3312
3. Alcaraz M.J., Vicente A.M., Araico A., Dominiguez J.N., Terencio M.C., and Ferrandiz M.L. Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of anti-inflammatory chalcone derivate in RAW 264.7 cells. Br. J. Pharmacol. 142 (2004) 1191-1199
4. Kohno Y., Kitamura S., Sanoh S., Sugihara K., Fujimoto N., and Ohta S. Metabolism of the α,β-unsaturated ketones, chalcone and trans-4-phenyl-3-buten-2-one, by rat liver microsomes and estrogenic activity of the metabolites. Drug Metab. Depos. 33 (2005) 1115-1123
5. Middleton Jr. E., Kandaswami C., and Theoharides T.C. The effect of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52 (2000) 673-751
6. Dimmock J.R., Elias D.W., Beazely M.A., and Kandepu N.M. Bioactivities of chalcones. Curr. Med. Chem. 6 (1999) 1125-1149
7. Go M.L., Wu X., and Liu X. Chalcones: an update on cytotoxic and chemopreventive properties. Curr. Med. Chem. 12 (2005) 483-499
8. Dimmock J.R., Kandepu N.M., Nazarali A.J., Kowalchuk T.P., Motaganahalli N., Quail J.W., et al. Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones. J. Med. Chem. 42 (1999) 1358-1366
9. Dimmock J.R., Zello G.A., Oloo E.O., Quail J.W., Kraatz H.B., Perjési P., et al. Correlations between cytotoxicity and various physicochemical parameters of some 2-arylidenebenzocyclanones established by X-ray crystallography and quantitative structure-activity relationship. J. Med. Chem. 45 (2002) 3103-3111
10. Perjési P., Das U., DeClerq E., Balzarini J., Kawase M., Sakagami H., et al. Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-one which display selective toxicity for malignant cells. Eur. J. Med. Chem. 43 (2008) 831-849
11. Perjési P., Gyöngyi Z., and Bayer Z. Effect of E-2-(4′-methoxybenzylidene)-1-benzosuberone on the 7,12-dimethylbenz[a]anthracene-induced onco/suppressor gene action in vivo II: a 48-hour experiment. Anticancer Res. 20 (2000) 1839-1848
12. Monostory K., Tamási V., Vereczkey L., and Perjési P. Study on CYPA1 inhibitory action of 4′-methoxybenzylidene-benzosuberone and some related cyclic chalcone derivatives. Toxicology 184 (2003) 203-210
13. Dinkova-Kostova A.T., Massiah M.A., Bozak R.E., Hicks R.J., and Talalay P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl. Acad. Sci. 98 (2001) 3404-3409
14. Rozmer Zs., Berki T., and Perjési P. Different effects of two cyclic chalcone analogues on cell cycle of Jurtkat T cells. Toxicol. in Vitro 20 (2006) 1354-1362
15. Perjési P., Kubálková J., Chovanová Z., Mareková M., Rozmer Z., Fodor K., Chavková Z., et al. Comparison of effects of some cyclic chalcone analogues on selected mitochondrial functions. Pharmazie 63 (2008) 899-903
16. Powis G., Gasdaska J.R., and Baker A. Redox signaling and the control of cell growth and death. In: Sies H. (Ed). Antioxidants in Disease Mechanisms and Therapy. Advances in Pharmacology vol. 38 (1997), Academic Press, San Diego 329-359
17. Wallace D.C. Mitochondrial diseases in man and mouse. Science 283 (1999) 1148-1482
18. Gregus Z., and Klaasen C.D. Mechanisms of toxicity. In: Klaasen C.D. (Ed). The Basic Science of Poisons. sixth ed. Casarett and Dull's Toxicology (2001), McGraw-Hill, New York 35-81 (Chapter 3)
19. Medina J., and Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 65 (2005) 2445-2461
20. Mesner Jr. P.W., Budihardjo I.I., and Kaufmann S.H. Chemotherapy-induced apoptosis. In: Kaufmann S.H. (Ed). Apoptosis. Pharmacological Implications and Therapeutic Opportunities. Advances in Pharmacology vol. 41 (1997), Academic Press, San Diego 461-499
21. Tomečkova V., Guzy J., Kusnír J., Marekova M., Chavkova Z., and Perjési P. Comparison of the effects of selected chalcones, dihydrochalcones and some cyclic flavonoids on mitochondrial outer membrane determined by fluorescence spectroscopy. J. Biochem. Biophys. Methods 69 (2006) 143-150
22. Johnson D., and Lardy H. Isolation of liver or kidney mitochondria. Methods Enzymol. 10 (1967) 94-96
23. Hartree R.F. Determination of protein: a modification of Lowry method that gives a linear photometric response. Anal. Biochem. 48 (1972) 422-427
24. Estabrook R.E. Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Methods Enzymol. 10 (1967) 41-47
25. Calberg I., and Mannervik B. Glutathione reductase. Methods Enzymol. 113 (1985) 484-485
26. Flohe L., and Gunzler W.A. Assay of glutathione peroxidase. Methods Enzymol. 105 (1984) 114-121
27. Abukhalaf I.K., Silvestrov N.A., Menter J.M., von Deutsch D.A., Bayorh M.A., Socci R.R., et al. High performance liquid chromatographic assay for the quantitation of total glutathione in plasma. J. Pharm. 28 (2002) 637-643
28. Boveris D.L., and Boveris A. Oxygen delivery to the tissues and mitochondrial respiration. Front. Biosci. 1 (2007) 1014-1023
29. Hodnick W.F., Milosavljevic E.B., Nelson J.H., and Pardini R.S. Electrochemistry of flavonoids. Relationships between redox potentials, inhibition of mitochondrial respiration, and production of oxygen radicals by flavonoids. Biochem. Pharmacol. 37 (1988) 2601-2611
30. Chen Q., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J. Pharmacol. Exp. Ther. 319 (2006) 1405-1412
31. Dorta D.J., Pigoso A.A., Mingatto F.E., Rodrigues T., Prado I.M., Helena A.F., et al. The interaction of flavonoids with mitochondria: effects on energetic processes. Chem. Biol. Interact. 152 (2005) 67-78
32. Trumbeckaite S., Bernatoniene J., Majiene D., Jakstas V., Savickas A., and Toleikis A. The effects of flavonoids on rat heart mitochondrial function. Biomed. Pharmacother. 60 (2006) 245-248
33. 2O and cumene hydroperoxide treatment on heart mitochondria. J. Bioenerg. Biomembr. 38 (2006) 121-127
34. Chance B., Sies H., and Boveris A. Hydroperoxides metabolism in mammalian organ. Physiol. Rev. 59 (1979) 72-77
35. Galati G., Tafazoli S., Sabzevari O., Chan T.S., and O'Brien P.J. Idiosyncratic NSAID drug induced oxidative stress. Chem. Biol. Interact. 142 (2002) 25-41